Encision Inc. (ECIA)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -640.78 Thousand USD | -111.48% |
| 2023 | -303 Thousand USD | 49.08% |
| 2022 | -595 Thousand USD | -875.41% |
| 2021 | -61 Thousand USD | 60.9% |
| 2020 | -156 Thousand USD | 16.29% |
| 2019 | -186.35 Thousand USD | -147.06% |
| 2018 | 396 Thousand USD | 157.56% |
| 2017 | -688 Thousand USD | 2.82% |
| 2016 | -708 Thousand USD | 40.25% |
| 2015 | -1.18 Million USD | 21.58% |
| 2014 | -1.51 Million USD | -174.74% |
| 2013 | -550 Thousand USD | -16.44% |
| 2012 | -472.35 Thousand USD | -1043.18% |
| 2011 | 50.08 Thousand USD | -83.63% |
| 2010 | 306 Thousand USD | 47.63% |
| 2009 | 207.27 Thousand USD | 234.14% |
| 2008 | -154.51 Thousand USD | -17.58% |
| 2007 | -131.41 Thousand USD | 62.83% |
| 2006 | -353.53 Thousand USD | 41.01% |
| 2005 | -599.31 Thousand USD | -7591.46% |
| 2004 | 8000.00 USD | -96.15% |
| 2003 | 207.85 Thousand USD | 190.13% |
| 2002 | -230.62 Thousand USD | 80.98% |
| 2001 | -1.21 Million USD | 41.79% |
| 2000 | -2.08 Million USD | 15.42% |
| 1999 | -2.46 Million USD | 31.41% |
| 1998 | -3.59 Million USD | -2.54% |
| 1997 | -3.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -128 Thousand USD | -60.0% |
| 2024 Q3 | -189.4 Thousand USD | -3256.67% |
| 2024 FY | -640.78 Thousand USD | -111.48% |
| 2024 Q4 | -402 Thousand USD | -112.25% |
| 2024 Q2 | 6000.00 USD | 104.69% |
| 2023 Q3 | -211 Thousand USD | 24.21% |
| 2023 FY | -303 Thousand USD | 49.08% |
| 2023 Q4 | -80 Thousand USD | 62.09% |
| 2023 Q2 | -278.4 Thousand USD | -204.27% |
| 2023 Q1 | 267 Thousand USD | 26600.0% |
| 2022 Q1 | -5000.00 USD | -103.25% |
| 2022 FY | -595 Thousand USD | -875.41% |
| 2022 Q4 | 1000.00 USD | 106.25% |
| 2022 Q3 | -16 Thousand USD | 90.59% |
| 2022 Q2 | -170 Thousand USD | -3300.0% |
| 2021 Q1 | -149 Thousand USD | -52.04% |
| 2021 FY | -61 Thousand USD | 60.9% |
| 2021 Q2 | -78 Thousand USD | 47.65% |
| 2021 Q4 | 154 Thousand USD | 1084.62% |
| 2021 Q3 | 13 Thousand USD | 116.67% |
| 2020 FY | -156 Thousand USD | 16.29% |
| 2020 Q4 | -98 Thousand USD | -213.95% |
| 2020 Q3 | 86 Thousand USD | 145.71% |
| 2020 Q1 | -179 Thousand USD | 1.05% |
| 2020 Q2 | 35 Thousand USD | 119.55% |
| 2019 Q2 | 40 Thousand USD | 5.26% |
| 2019 FY | -186.35 Thousand USD | -147.06% |
| 2019 Q4 | -180.9 Thousand USD | -115.36% |
| 2019 Q3 | -84 Thousand USD | -310.0% |
| 2019 Q1 | 38 Thousand USD | 2000.0% |
| 2018 FY | 396 Thousand USD | 157.56% |
| 2018 Q3 | 71 Thousand USD | -44.96% |
| 2018 Q4 | -2000.00 USD | -102.82% |
| 2018 Q2 | 129 Thousand USD | -34.85% |
| 2018 Q1 | 198 Thousand USD | 298.0% |
| 2017 Q2 | -244 Thousand USD | -187.06% |
| 2017 Q4 | -100 Thousand USD | 61.24% |
| 2017 FY | -688 Thousand USD | 2.82% |
| 2017 Q1 | -85 Thousand USD | 68.16% |
| 2017 Q3 | -258 Thousand USD | -5.74% |
| 2016 Q2 | -122 Thousand USD | 29.48% |
| 2016 FY | -708 Thousand USD | 40.25% |
| 2016 Q4 | -267 Thousand USD | -82.88% |
| 2016 Q3 | -146 Thousand USD | -19.67% |
| 2016 Q1 | -173 Thousand USD | 44.55% |
| 2015 Q4 | -312 Thousand USD | 14.05% |
| 2015 FY | -1.18 Million USD | 21.58% |
| 2015 Q1 | -146 Thousand USD | 89.55% |
| 2015 Q2 | -364 Thousand USD | -149.32% |
| 2015 Q3 | -363 Thousand USD | 0.27% |
| 2014 Q1 | -164 Thousand USD | 23.72% |
| 2014 Q3 | 98 Thousand USD | 326.09% |
| 2014 Q2 | 23 Thousand USD | 114.02% |
| 2014 FY | -1.51 Million USD | -174.74% |
| 2014 Q4 | -1.39 Million USD | -1525.9% |
| 2013 Q3 | -83 Thousand USD | 68.44% |
| 2013 Q1 | 11 Thousand USD | -77.68% |
| 2013 Q2 | -263 Thousand USD | -2490.91% |
| 2013 FY | -550 Thousand USD | -16.44% |
| 2013 Q4 | -215 Thousand USD | -159.04% |
| 2012 Q1 | -7824.00 USD | -117.43% |
| 2012 Q4 | 49.27 Thousand USD | 179.26% |
| 2012 Q2 | -451.76 Thousand USD | -5674.04% |
| 2012 Q3 | -62.17 Thousand USD | 86.24% |
| 2012 FY | -472.35 Thousand USD | -1043.18% |
| 2011 Q4 | 44.88 Thousand USD | -81.87% |
| 2011 Q1 | -109.35 Thousand USD | -15.68% |
| 2011 FY | 50.08 Thousand USD | -83.63% |
| 2011 Q3 | 247.53 Thousand USD | 286.14% |
| 2011 Q2 | -132.98 Thousand USD | -21.61% |
| 2010 FY | 306 Thousand USD | 47.63% |
| 2010 Q1 | 178.3 Thousand USD | 427.43% |
| 2010 Q2 | 61.83 Thousand USD | -65.32% |
| 2010 Q3 | 160.3 Thousand USD | 159.25% |
| 2010 Q4 | -94.53 Thousand USD | -158.97% |
| 2009 Q2 | 92.03 Thousand USD | 155.65% |
| 2009 Q4 | 33.8 Thousand USD | -86.3% |
| 2009 Q1 | -165.39 Thousand USD | -372.03% |
| 2009 FY | 207.27 Thousand USD | 234.14% |
| 2009 Q3 | 246.82 Thousand USD | 168.18% |
| 2008 Q1 | -288.14 Thousand USD | -60.37% |
| 2008 Q4 | 60.8 Thousand USD | -9.29% |
| 2008 Q3 | 67.03 Thousand USD | 1055.69% |
| 2008 Q2 | 5800.00 USD | 102.01% |
| 2008 FY | -154.51 Thousand USD | -17.58% |
| 2007 Q3 | -60.85 Thousand USD | -604.64% |
| 2007 Q2 | 12.05 Thousand USD | -87.57% |
| 2007 FY | -131.41 Thousand USD | 62.83% |
| 2007 Q4 | -179.68 Thousand USD | -195.26% |
| 2007 Q1 | 97 Thousand USD | 301.63% |
| 2006 Q1 | 14.24 Thousand USD | 113.18% |
| 2006 Q4 | -48.1 Thousand USD | 69.76% |
| 2006 Q3 | -159.09 Thousand USD | 0.92% |
| 2006 Q2 | -160.57 Thousand USD | -1226.94% |
| 2006 FY | -353.53 Thousand USD | 41.01% |
| 2005 Q1 | -291.12 Thousand USD | -342.25% |
| 2005 Q3 | -142.94 Thousand USD | -150.16% |
| 2005 Q2 | -57.14 Thousand USD | 80.37% |
| 2005 FY | -599.31 Thousand USD | -7591.46% |
| 2005 Q4 | -108.1 Thousand USD | 24.37% |
| 2004 Q4 | -65.82 Thousand USD | -3701.04% |
| 2004 FY | 8000.00 USD | -96.15% |
| 2004 Q3 | 1828.00 USD | -94.83% |
| 2004 Q2 | 35.33 Thousand USD | -3.61% |
| 2004 Q1 | 36.66 Thousand USD | -38.07% |
| 2003 Q3 | 147.82 Thousand USD | 64.94% |
| 2003 Q2 | 89.62 Thousand USD | 200.94% |
| 2003 FY | 207.85 Thousand USD | 190.13% |
| 2003 Q1 | -88.78 Thousand USD | -27.98% |
| 2003 Q4 | 59.19 Thousand USD | -59.96% |
| 2002 Q2 | 29.55 Thousand USD | 139.01% |
| 2002 Q1 | -75.76 Thousand USD | 77.85% |
| 2002 Q3 | -115.03 Thousand USD | -489.2% |
| 2002 Q4 | -69.37 Thousand USD | 39.69% |
| 2002 FY | -230.62 Thousand USD | 80.98% |
| 2001 FY | -1.21 Million USD | 41.79% |
| 2001 Q4 | -342.04 Thousand USD | -50.16% |
| 2001 Q3 | -227.78 Thousand USD | 14.1% |
| 2001 Q2 | -265.16 Thousand USD | 29.72% |
| 2001 Q1 | -377.27 Thousand USD | 44.08% |
| 2000 Q3 | -518.1 Thousand USD | 0.0% |
| 2000 Q4 | -674.62 Thousand USD | -30.21% |
| 2000 FY | -2.08 Million USD | 15.42% |
| 1999 FY | -2.46 Million USD | 31.41% |
| 1998 FY | -3.59 Million USD | -2.54% |
| 1997 FY | -3.5 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 155.04% |
| Ansell Limited | 129.3 Million USD | 100.496% |
| Ansell Limited | 129.3 Million USD | 100.496% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 102.058% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 59.843% |
| Psykey, Inc. | -797.5 Thousand USD | 19.651% |
| ConvaTec Group Plc | 262.7 Million USD | 100.244% |
| ConvaTec Group Plc | 262.7 Million USD | 100.244% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -351.86% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -482.901% |
| Innovative MedTech Inc. | -4.27 Million USD | 85.008% |
| LifePoint, Inc. | -7.49 Million USD | 91.451% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 90.111% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 294.177% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -421.428% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -37.131% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.734% |
| Sector 10, Inc. | -39.84 Thousand USD | -1508.23% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.2% |
| SheerVision, Inc. | 155.72 Thousand USD | 511.481% |
| United Health Products, Inc. | -2.42 Million USD | 73.593% |
| Vasamed, Inc. | 4.74 Million USD | 113.512% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 72.069% |
| Yubo International Biotech Limited | -1.2 Million USD | 46.833% |